中华耳鼻咽喉头颈外科杂志
中華耳鼻嚥喉頭頸外科雜誌
중화이비인후두경외과잡지
CHINESE JOURNAL OF OTORHINOLARYNGOLOGY HEAD AND NECK SURGERY
2012年
1期
26-29
,共4页
别远志%孙敬武%孙家强%郭涛
彆遠誌%孫敬武%孫傢彊%郭濤
별원지%손경무%손가강%곽도
内窥镜检查%耳鼻喉外科手术%头颈部肿瘤%鼻泪管%鼻甲
內窺鏡檢查%耳鼻喉外科手術%頭頸部腫瘤%鼻淚管%鼻甲
내규경검사%이비후외과수술%두경부종류%비루관%비갑
Endoscopy%Otorhinolaryngologic surgical procedures%Head and neck neoplasms%Nasolacrimal duct%Turbinates
目的 探讨内镜经鼻腔泪前隐窝-上颌窦入路在翼腭窝病变手术中的应用.方法 回顾性分析2008年5月至2011年5月5例翼腭窝良性肿瘤患者的病例资料,5例患者均接受了内镜经鼻腔泪前隐窝-上颌窦入路的外科治疗.其中神经鞘瘤4例,神经纤维瘤1例.手术采用控制低血压全身麻醉,鼻内镜下泪前隐窝入路切开鼻腔外侧壁进入上颌窦,切开上颌窦后壁进入翼腭窝切除肿瘤.结果 本组5例肿瘤均获得一次性完全切除,无任何并发症.均于术后5～12 d痊愈出院.术后随访5～28个月无复发和死亡.结论 内镜经鼻腔泪前隐窝-上颌窦入路可以安全而完整地切除翼腭窝的良性肿瘤.该术式保留了鼻泪管和下鼻甲,保留鼻腔结构和功能,从而更好地降低复发率和缩短恢复时间.
目的 探討內鏡經鼻腔淚前隱窩-上頜竇入路在翼腭窩病變手術中的應用.方法 迴顧性分析2008年5月至2011年5月5例翼腭窩良性腫瘤患者的病例資料,5例患者均接受瞭內鏡經鼻腔淚前隱窩-上頜竇入路的外科治療.其中神經鞘瘤4例,神經纖維瘤1例.手術採用控製低血壓全身痳醉,鼻內鏡下淚前隱窩入路切開鼻腔外側壁進入上頜竇,切開上頜竇後壁進入翼腭窩切除腫瘤.結果 本組5例腫瘤均穫得一次性完全切除,無任何併髮癥.均于術後5～12 d痊愈齣院.術後隨訪5～28箇月無複髮和死亡.結論 內鏡經鼻腔淚前隱窩-上頜竇入路可以安全而完整地切除翼腭窩的良性腫瘤.該術式保留瞭鼻淚管和下鼻甲,保留鼻腔結構和功能,從而更好地降低複髮率和縮短恢複時間.
목적 탐토내경경비강루전은와-상합두입로재익악와병변수술중적응용.방법 회고성분석2008년5월지2011년5월5례익악와량성종류환자적병례자료,5례환자균접수료내경경비강루전은와-상합두입로적외과치료.기중신경초류4례,신경섬유류1례.수술채용공제저혈압전신마취,비내경하루전은와입로절개비강외측벽진입상합두,절개상합두후벽진입익악와절제종류.결과 본조5례종류균획득일차성완전절제,무임하병발증.균우술후5～12 d전유출원.술후수방5～28개월무복발화사망.결론 내경경비강루전은와-상합두입로가이안전이완정지절제익악와적량성종류.해술식보류료비루관화하비갑,보류비강결구화공능,종이경호지강저복발솔화축단회복시간.
Objective To explore the application of endoscopic transnasal prelacrimal recessmaxillary sinus approach in surgery for lesions in the pterygopalatine fossa.Methods Five patients with tumors of pterygopalatine fossa were treated by endoscopic transnasal prelacrimal recess-maxillary sinus surgery between May 2008 and May 2011.The lesions treated included 4 schwannoma and 1 neurofibroma.The operation began with endoscopic transnasal lateral nasal wall approach to maxillary sinus.Then after opening posterior wall of maxillary sinus,the pterygopalatine fossa was entered and the tumor was removed.The operation was performed under hypotension anaesthesia.Results The tumors were removed totally in all 5 patients.No complication was found.After the surgery,all patients fully recovered and were discharged from the hospital in 5 to 12 days.No recurrence and death occurred during the follow up periods ranging from 5 to 28 months.Conclusions Endoscopic transnasal prelacrimal recess-maxillary sinus approach is safe and effective management for benign tumors in the pterygopalatine fossa.This approach reserved nasolacrimal duct and turbinate,maintained the structure and function of the nose,with decreased morbidity and shorter recovery periods.
